艾美疫苗半年收入同比降31.87%,亏损1.23亿元

财中社
Aug 23

8月23日,艾美疫苗(06660)发布截至2026年6月30日止六个月的业绩。公司在此期间的收入为3.51亿元,较2025年同期的5.15亿元下降31.87%。毛利为2.46亿元,同比下降27.98%。母公司拥有者应占亏损为1.23亿元。收入下降的主要原因包括国家增值税政策调整、行业舆情影响、市场竞争加剧以及采购周期变化。  在管理层讨论与分析部分,公司提到疫苗销售收入一类疫苗为1299万元,较...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10